NAAC Board Members
President
Aryeh Shander, MD, FCCM, FCCP
Vice President/President Elect
William B. Ershler, MD
Immediate Past President
Richard K. Spence, MD
Secretary/Treasurer
Andrew Artz, MD, MS
At-Large Members
Arnold J. Friedman, MD
Sherri Ozawa, RN
Members
Inder Anand, MD, FRCP, DPHIL
Lodovico Balducci, MD
Jeffrey S. Berns, MD
Richard D. Brasington, Jr., MD
Paul W. Crawford, MD
Daniel E. Furst, MD
Janet B. McGill, MD
Allen R. Nissenson, MD, FACP
Ileana Piña, MD
Lloyd P. Van Winkle, MD
Bradley A. Warady, MD
Roslyn Yomtovian, MD
Allen R. Nissenson, MD, FACP
Development Task Force Chair
Chief Medical Officer
DaVita, Inc.
Specialty: Nephrology
Allen R. Nissenson is the Chief Medical Officer for DaVita Inc., one of the largest independent dialysis services providers in the United States, and Emeritus Professor of Medicine at the David Geffen School of Medicine at UCLA where he also served as Associate Dean and Director of the Dialysis Program until 2008. He was recruited to UCLA in 1977, where he developed a comprehensive dialysis program with significant components including administration, patient care, teaching, and research. Dr. Nissenson is a past president of the National Anemia Action Council (NAAC).
Dr. Nissenson has served as Chair of the Southern California End-Stage Renal Disease (ESRD) Network during its organizational years in the early 1980s, and is now serving as President. He has long been involved in issues of health care delivery, and has consulted for the Rand Corporation and Pacificare on the development of capitation models for ESRD used in a seminal HCFA Demonstration Project in this area.
Dr. Nissenson served as a Robert Wood Johnson Health Policy Fellow of the Institute of Medicine in 1994-5, working in the office of the late Senator Paul Wellstone. He has served as President of the Renal Physicians Association, the national organization of nephrologists concerned with socioeconomic and clinical practice issues in nephrology, and remains on the Board of Directors as Counselor. He has served as a member of the Advisory Group overseeing the entire Dialysis Outcomes Quality Initiative of the National Kidney Foundation (NKF-DOQI), as well as serving as a member of the anemia work group.
Dr. Nissenson is the author of two dialysis textbooks, both in their fourth editions and was the founding Editor-in-Chief of Advances in Renal Replacement Therapy, an official journal of the National Kidney Foundation. He is currently Editor-in-Chief of Hemodialysis International, the official journal of the International Society for Hemodialysis. He has over 500 publications in the field of nephrology, dialysis, anemia management, and health care delivery and policy. Among his numerous honors is the President's Award of the National Kidney Foundation. In 2007 he received the Lifetime Achievement Award in Hemodialysis presented by the University of Missouri on behalf of the Annual Dialysis Conference.
Last Updated: January 26, 2009
